Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer. - Wikidata - awgldk - TriplyDB

Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer.

Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer.

http://www.wikidata.org/entity/Q37722185

about

Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.

P2860

Q36153838-779E23D4-2642-42E5-AE52-615CF9E77F77

P2860

Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer.

http://www.wikidata.org/entity/Q37722185

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anthracycline-based induction ...... y node-positive breast cancer.

@en

Anthracycline-based induction ...... y node-positive breast cancer.

@nl

type

label

Anthracycline-based induction ...... y node-positive breast cancer.

@en

Anthracycline-based induction ...... y node-positive breast cancer.

@nl

prefLabel

Anthracycline-based induction ...... y node-positive breast cancer.

@en

Anthracycline-based induction ...... y node-positive breast cancer.

@nl

P1433

Q37722185-35700E3B-EF7F-4CB7-A3F6-76DB0C4BB353

P1476

Q37722185-0AF7469A-C19D-4D59-9D0B-5A3BB8BEA63A

P2093

Q37722185-5FC6AB0F-B3A8-49A5-A4F9-1FAB4911F1B8

Q37722185-713E0751-1B6F-4479-96A4-95DC591EE07A

Q37722185-7F79D15A-224D-4E38-9072-5B97AD8A4D6C

Q37722185-89806F50-02E1-420F-B4E5-6B84F69A941E

Q37722185-89DC6CF8-476C-4F56-BF79-02A993FCFB03

Q37722185-9B74A097-DD55-4188-A0FD-D4D61855C09F

Q37722185-A94F6346-7E5F-4D97-A7AA-C4BEA3433A96

Q37722185-B04B13B3-5547-4BBF-8F72-0E723A133922

P2860

Q37722185-0E32A720-EC69-4A0F-BF9C-1CD807345E6D

Q37722185-237ECE7E-4203-44BF-8612-6082E4854A7B

Q37722185-34FA3F0F-0E98-41C4-BA1F-77DC39C5AD01

Q37722185-3FE99F23-425B-444C-B3D3-7FB740F5A453

Q37722185-53FBDC78-E81A-4840-871A-D19475370908

Q37722185-79E3462C-7A5B-4400-B05E-B95242BBC95D

Q37722185-9AD4259C-FD94-49DD-A8CA-6485CBD158B5

Q37722185-9BC17BA0-49D5-46DB-83C1-F7B925FEB5E0

Q37722185-9E8F0121-9897-4073-8375-6FEC2FFDBC4C

Q37722185-A0DD7848-C619-42AD-9F75-5F965ADDE805

P304

Q37722185-7568FC2B-5BAA-4F01-8D56-DE4BEADAD4E7

P31

Q37722185-42D225EC-4528-46E3-87C2-66A9286746B2

P356

Q37722185-61B77D92-FAD0-4082-8753-9236165D4B39

P433

Q37722185-95A06346-59AF-48C6-8AFD-500153CAA78D

P478

Q37722185-28E746FB-531D-417B-88B0-0A662A7E0AF9

P50

Q37722185-4A708F3F-88EC-4743-881C-C0E7C324EEFE

P577

Q37722185-B50DE7A5-02CB-46F0-B1B7-46346D27F556

P5875

Q37722185-E9487489-EC32-4BBB-9349-D5A1FFF310DA

P698

Q37722185-8812E890-0457-4097-BD9F-6967366E6A6E

P921

Q37722185-6F5DC929-9172-41D4-906C-D88F883BE5DE

Q37722185-F8AB61D8-473C-4527-B378-F4E54048744B

P932

Q37722185-51EC23E3-1E7C-4261-94B3-901E6B42319E

P356

P1433

Molecular and clinical oncology

P1476

Anthracycline-based induction ...... y node-positive breast cancer.

@en

P2093

Alisia Cesta

http://www.w3.org/2001/XMLSchema#string

Ernesto DI Cesare

http://www.w3.org/2001/XMLSchema#string

Francesco Recchia

http://www.w3.org/2001/XMLSchema#string

Giampiero Candeloro

http://www.w3.org/2001/XMLSchema#string

Giovanni Luca Gravina

http://www.w3.org/2001/XMLSchema#string

Mario DI Staso

http://www.w3.org/2001/XMLSchema#string

Pierluigi Bonfili

http://www.w3.org/2001/XMLSchema#string

Stefano Necozione

http://www.w3.org/2001/XMLSchema#string

P2860

Sequencing of chemotherapy and radiotherapy for early breast cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

High-dose carboplatin, cyclophosphamide, etoposide with hematological growth factors, without stem cell support in patients with advanced cancer.

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study.

Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer

High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

P304

473-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2014.269

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261923185

http://www.w3.org/2001/XMLSchema#string

P698

24772320

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3999139

http://www.w3.org/2001/XMLSchema#string